These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 21995574)
1. Variation of tumor-infiltrating lymphocytes in human cancers: controversy on clinical significance. Sasada T; Suekane S Immunotherapy; 2011 Oct; 3(10):1235-51. PubMed ID: 21995574 [TBL] [Abstract][Full Text] [Related]
2. Current concepts of tumor-infiltrating lymphocytes in human malignancies. Chiou SH; Sheu BC; Chang WC; Huang SC; Hong-Nerng H J Reprod Immunol; 2005 Oct; 67(1-2):35-50. PubMed ID: 16111767 [TBL] [Abstract][Full Text] [Related]
3. Increased infiltration of activated tumor-infiltrating lymphocytes after high intensity focused ultrasound ablation of human breast cancer. Lu P; Zhu XQ; Xu ZL; Zhou Q; Zhang J; Wu F Surgery; 2009 Mar; 145(3):286-93. PubMed ID: 19231581 [TBL] [Abstract][Full Text] [Related]
4. T cell functions of IL-2-activated tumor-infiltrating lymphocytes from renal cell carcinoma. Morita T; Salmeron MA; Hayakawa K; Swanson DA; von Eschenbach AC; Itoh K Reg Immunol; 1992; 4(4):225-35. PubMed ID: 1476875 [TBL] [Abstract][Full Text] [Related]
5. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma. Gao YW; Chen YX; Wang ZM; Zhou LD; Li XY; Li LX; Luo QZ; Tian W; Fu CY; Zhou JH Hepatogastroenterology; 2008; 55(82-83):345-50. PubMed ID: 18613363 [TBL] [Abstract][Full Text] [Related]
6. NKR-P1+ cells localize selectively in Rat 9L gliosarcomas but have reduced cytolytic function. Chambers WH; Bozik ME; Brissette-Storkus SC; Basse P; Redgate E; Watkins S; Boggs SS Cancer Res; 1996 Aug; 56(15):3516-25. PubMed ID: 8758920 [TBL] [Abstract][Full Text] [Related]
7. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma. Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295 [TBL] [Abstract][Full Text] [Related]
8. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity. Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123 [TBL] [Abstract][Full Text] [Related]
9. Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk. Xu X; Li J; Zou J; Feng X; Zhang C; Zheng R; Duanmu W; Saha-Mandal A; Ming Z; Wang E JAMA Netw Open; 2019 Sep; 2(9):e199292. PubMed ID: 31483464 [TBL] [Abstract][Full Text] [Related]
10. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Unitt E; Rushbrook SM; Marshall A; Davies S; Gibbs P; Morris LS; Coleman N; Alexander GJ Hepatology; 2005 Apr; 41(4):722-30. PubMed ID: 15791620 [TBL] [Abstract][Full Text] [Related]
12. Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines. Mulders P; Tso CL; Gitlitz B; Kaboo R; Hinkel A; Frand S; Kiertscher S; Roth MD; deKernion J; Figlin R; Belldegrun A Clin Cancer Res; 1999 Feb; 5(2):445-54. PubMed ID: 10037196 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of tumor-infiltrating lymphocytes in neoplastic progression and lymph node metastasis of human breast cancer. Sheu BC; Kuo WH; Chen RJ; Huang SC; Chang KJ; Chow SN Breast; 2008 Dec; 17(6):604-10. PubMed ID: 18656354 [TBL] [Abstract][Full Text] [Related]
14. Controversies on the prognostic significance of tumor infiltrating leukocytes in solid human tumors. Bodey B; Bodey B; Siegel SE; Kaiser HE Anticancer Res; 2000; 20(3A):1759-68. PubMed ID: 10928105 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma. Finke JH; Rayman P; Alexander J; Edinger M; Tubbs RR; Connelly R; Pontes E; Bukowski R Cancer Res; 1990 Apr; 50(8):2363-70. PubMed ID: 2107973 [TBL] [Abstract][Full Text] [Related]
16. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Ichihara F; Kono K; Takahashi A; Kawaida H; Sugai H; Fujii H Clin Cancer Res; 2003 Oct; 9(12):4404-8. PubMed ID: 14555512 [TBL] [Abstract][Full Text] [Related]
17. Expression of inhibitory receptors in natural killer (CD3(-)CD56(+)) cells and CD3(+)CD56(+) cells in the peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with primary hepatocellular carcinoma. Yuen MF; Norris S Clin Immunol; 2001 Dec; 101(3):264-9. PubMed ID: 11726217 [TBL] [Abstract][Full Text] [Related]
18. Differing phenotypes between intraepithelial and stromal lymphocytes in early-stage tongue cancer. Katou F; Ohtani H; Watanabe Y; Nakayama T; Yoshie O; Hashimoto K Cancer Res; 2007 Dec; 67(23):11195-201. PubMed ID: 18056444 [TBL] [Abstract][Full Text] [Related]
19. [Function and prognostic significance of immune cells infiltrating human tumors]. Ladányi A Magy Onkol; 2004; 48(1):49-56. PubMed ID: 15105896 [TBL] [Abstract][Full Text] [Related]
20. Phenotypic analysis of tumor-infiltrating lymphocytes in hepatocellular carcinoma. Chen CH; Lee HS; Huang GT; Yang PM; Yu WY; Cheng KC; Lee PH; Jeng YM; Chen DS; Sheu JC Hepatogastroenterology; 2007; 54(77):1529-33. PubMed ID: 17708291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]